Literature DB >> 25177526

Histones: Controlling Tumor Signaling Circuitry.

Manoela D Martins1, Rogerio M Castilho2.   

Abstract

Epigenetic modifications constitute the next frontier in tumor biology research. Post-translation modification of histones dynamically influences gene expression independent of alterations to the DNA sequence. These mechanisms are often mediated by histone linkers or by proteins associated with the recruitment of DNA-binding proteins, HDAC I and II interacting proteins and transcriptional activators, coactivators or corepressors. Early evidence suggested that histones and their modifiers are involved in sophisticated processes that modulate tumor behavior and cellular phenotype. In this review, we discuss how recent discoveries about chromatin modifications, particularly histone acetylation, are shaping our knowledge of cell biology and our understanding of the molecular circuitry governing tumor progression and consider whether recent insights may extend to novel therapeutic approaches. Furthermore, we discuss the latest oncogenomic findings in Head and Neck Squamous Cell Carcinoma (HNSCC) from studies using Next Generation Sequencing (NGS) technology and highlight the impact of mutations identified in histones and their modifiers.

Entities:  

Keywords:  Acetylation; Chromatin compaction; Genetic code; H3; H4; Histone modifications; Oral cancer; Whole genome sequencing

Year:  2013        PMID: 25177526      PMCID: PMC4149316          DOI: 10.4172/2157-2518.S5-001

Source DB:  PubMed          Journal:  J Carcinog Mutagen


  148 in total

1.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

3.  Vorinostat.

Authors:  Steven Grant; Chris Easley; Peter Kirkpatrick
Journal:  Nat Rev Drug Discov       Date:  2007-01       Impact factor: 84.694

Review 4.  Epigenetic therapy of cancer: past, present and future.

Authors:  Christine B Yoo; Peter A Jones
Journal:  Nat Rev Drug Discov       Date:  2006-01       Impact factor: 84.694

5.  Acetylation of histone H4 plays a primary role in enhancing transcription factor binding to nucleosomal DNA in vitro.

Authors:  M Vettese-Dadey; P A Grant; T R Hebbes; C Crane- Robinson; C D Allis; J L Workman
Journal:  EMBO J       Date:  1996-05-15       Impact factor: 11.598

6.  Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose.

Authors:  K G Tanner; J Landry; R Sternglanz; J M Denu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

7.  Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification.

Authors:  Minjia Tan; Hao Luo; Sangkyu Lee; Fulai Jin; Jeong Soo Yang; Emilie Montellier; Thierry Buchou; Zhongyi Cheng; Sophie Rousseaux; Nisha Rajagopal; Zhike Lu; Zhen Ye; Qin Zhu; Joanna Wysocka; Yang Ye; Saadi Khochbin; Bing Ren; Yingming Zhao
Journal:  Cell       Date:  2011-09-16       Impact factor: 41.582

8.  Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity.

Authors:  Priya Kapoor-Vazirani; Jacob D Kagey; Doris R Powell; Paula M Vertino
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

Review 9.  Histone deacetylases in neural stem cells and induced pluripotent stem cells.

Authors:  Guoqiang Sun; Chelsea Fu; Caroline Shen; Yanhong Shi
Journal:  J Biomed Biotechnol       Date:  2011-08-07

10.  Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy.

Authors:  W Weichert; A Röske; V Gekeler; T Beckers; C Stephan; K Jung; F R Fritzsche; S Niesporek; C Denkert; M Dietel; G Kristiansen
Journal:  Br J Cancer       Date:  2008-01-22       Impact factor: 7.640

View more
  10 in total

1.  Photobiomodulation therapy improves human dental pulp stem cell viability and migration in vitro associated to upregulation of histone acetylation.

Authors:  Ivana M Zaccara; Letícia B Mestieri; Emily F S Pilar; Maria S Moreira; Fabiana S Grecca; Manoela D Martins; Patrícia Maria Poli Kopper
Journal:  Lasers Med Sci       Date:  2020-02-24       Impact factor: 3.161

Review 2.  Histone modifications: Targeting head and neck cancer stem cells.

Authors:  John M Le; Cristiane H Squarize; Rogerio M Castilho
Journal:  World J Stem Cells       Date:  2014-11-26       Impact factor: 5.326

3.  A Mutation in Histone H2B Represents a New Class of Oncogenic Driver.

Authors:  Richard L Bennett; Aditya Bele; Eliza C Small; Christine M Will; Behnam Nabet; Jon A Oyer; Xiaoxiao Huang; Rajarshi P Ghosh; Adrian T Grzybowski; Tao Yu; Qiao Zhang; Alberto Riva; Tanmay P Lele; George C Schatz; Neil L Kelleher; Alexander J Ruthenburg; Jan Liphardt; Jonathan D Licht
Journal:  Cancer Discov       Date:  2019-07-23       Impact factor: 39.397

4.  Interference with the bromodomain epigenome readers drives p21 expression and tumor senescence.

Authors:  Liana P Webber; Veronica Q Yujra; Pablo A Vargas; Manoela D Martins; Cristiane H Squarize; Rogerio M Castilho
Journal:  Cancer Lett       Date:  2019-06-29       Impact factor: 8.679

5.  A Catalogue of Altered Salivary Proteins Secondary to Invasive Ductal Carcinoma: A Novel In Vivo Paradigm to Assess Breast Cancer Progression.

Authors:  Charles F Streckfus; Lenora Bigler
Journal:  Sci Rep       Date:  2016-08-01       Impact factor: 4.379

Review 6.  Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.

Authors:  Rogerio M Castilho; Cristiane H Squarize; Luciana O Almeida
Journal:  Int J Mol Sci       Date:  2017-07-12       Impact factor: 5.923

7.  Epigenetic Modifications and Accumulation of DNA Double-Strand Breaks in Oral Lichen Planus Lesions Presenting Poor Response to Therapy.

Authors:  Caroline S Dillenburg; Marco A T Martins; Luciana O Almeida; Luise Meurer; Cristiane H Squarize; Manoela D Martins; Rogerio M Castilho
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

8.  Sensitizing mucoepidermoid carcinomas to chemotherapy by targeted disruption of cancer stem cells.

Authors:  Douglas M Guimarães; Luciana O Almeida; Manoela D Martins; Kristy A Warner; Alan R S Silva; Pablo A Vargas; Fabio D Nunes; Cristiane H Squarize; Jacques E Nör; Rogerio M Castilho
Journal:  Oncotarget       Date:  2016-07-05

Review 9.  Current Concepts of Epigenetics and Its Role in Periodontitis.

Authors:  Lena Larsson
Journal:  Curr Oral Health Rep       Date:  2017-11-06

10.  Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.

Authors:  Vivian P Wagner; Manoela D Martins; Marco A T Martins; Luciana O Almeida; Kristy A Warner; Jacques E Nör; Cristiane H Squarize; Rogerio M Castilho
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.